Roivant Sciences GAAP EPS of -$0.17 beats by $0.16, revenue of $1.57M misses by $5.35M

* Roivant Sciences press release [https://seekingalpha.com/pr/20300059-roivant-reports-financial-results-for-the-second-quarter-ended-september-30-2025-and-provides] (ROIV [https://seekingalpha.com/symbol/ROIV]): Q2 GAAP EPS of -$0.17 beats by $0.16.
* Revenue of $1.57M (-65.0% Y/Y) misses by $5.35M.

MORE ON ROIVANT SCIENCES

* Roivant Sciences Ltd. (ROIV) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4825714-roivant-sciences-ltd-roiv-presents-at-bernstein-2nd-annual-global-healthcare-conference]
* Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2025 Transcript [https://seekingalpha.com/article/4825683-roivant-sciences-ltd-roiv-presents-at-bank-of-america-global-healthcare-conference-2025]
* Roivant Sciences Ltd. (ROIV) Q1 2024 Earnings Call Transcript [https://seekingalpha.com/article/4712808-roivant-sciences-ltd-roiv-q1-2024-earnings-call-transcript]
* Roivant Sciences Q2 2026 Earnings Preview [https://seekingalpha.com/news/4518652-roivant-sciences-q2-2026-earnings-preview]
* Baron Health Care Fund buys ABBV, UNH, ROIV; exits WAT and COO [https://seekingalpha.com/news/4509225-baron-health-care-fund-buys-abbv-unh-roiv-exits-wat-and-coo]